Rundong Jiang

Rundong Jiang

Auto-generated profile, based on publicly available information

Rundong Jiang

Department of Dermatology, University of Michigan, Ann Arbor, MI, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZFZhiqin Fang
Zhiqin Fang
YWYutong Wang
Yutong Wang
BHBo Huang
Bo Huang
XCXiang Chen
Xiang Chen
RJRundong Jiang
Rundong Jiang
MYMingzhu Yin
Mingzhu Yin
Psoriasis is a common and recurrent inflammatory skin disease characterized by inflammatory cells infiltration of the dermis and excessive proliferation, reduced apoptosis, and abnormal keratosis of the epidermis. In this study, we found that G9A, an important methyltransferase that mainly mediates the mono-methylation (me1) and di-methylation (me2) of histone 3 lysine 9 (H3K9), is highly expressed in lesions of patients with psoriasis and imiquimod (IMQ)-induced psoriasis-like mouse model. Previous studies have shown that G9A is involved in the pathogenesis of various tumors by regulating apoptosis, proliferation, differentiation, and invasion. However, the role of G9A in skin inflammatory diseases such as psoriasis remains unclear. Our data so far suggest that topical administration of G9A inhibitor BIX01294 as well as keratinocyte-specific deletion of G9A greatly alleviated IMQ-induced psoriatic alterations in mice for the first time. Mechanistically, the loss function of G9A causes the downregulation of Ectodysplasin A receptor (EDAR), consequently inhibiting the activation of NF-κB pathway, resulting in impaired proliferation and increased apoptosis of keratinocytes, therefore ameliorating the psoriatic dermatitis induced by IMQ. In total, we show that inhibition of G9A improves psoriatic-like dermatitis mainly by regulating cell proliferation and apoptosis rather than inflammatory processes, and that this molecule may be considered as a potential therapeutic target for keratinocyte hyperproliferative diseases such as psoriasis.

23 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
RJRundong Jiang
Rundong Jiang
JKJoseph Kirma
Joseph Kirma
JFJennifer Fox
Jennifer Fox
XXXianying Xing
Xianying Xing
JWJiaqi Wang
Jiaqi Wang
JGJohann Gudjonsson
Johann Gudjonsson
Generalized pustular psoriasis (GPP) is a severe subtype of psoriasis characterized by epidermal neutrophil infiltration, often presenting as acute, potentially life-threatening flares. However, the characterization of the immune micro-environment in GPP lesions remains largely unknown. Here, we use single-cell RNA profiling to interrogate the transcriptomes of 60,000 single cells from GPP lesional skin (n = 13) and healthy adult skin (n = 4), combined with spatial transcriptomics. We identify a neutrophil subset lacking CASP8 expression but exhibiting elevated levels of inflammatory pathway genes, including RIPK1, NFKB1, IL1B, CXCL1, and CXCL8 in GPP flares, illustrating neutrophil transition from pre-inflammatory to a pro-inflammatory state, and activation of a communication network between IL36G+ keratinocytes and neutrophils in GPP lesions, with TNFSF15 (TL1A) released from neutrophils exaggerating the inflammatory crosstalk. We further demonstrate that fibroblasts and capillary endothelial cells function as central communication hubs in GPP, through dynamic receptor-ligand interactions with several spatially proximate immune cells, including T cells, neutrophils, and macrophages. In this work, we provide an in-depth view of immune cell participation and highlight the role of neutrophil-keratinocyte crosstalk in GPP pathogenesis.

28 May 2026 in Immunity
Verified
Journal Article
Closed access
RJRundong Jiang
Rundong Jiang
ABAndrew Blauvelt
Andrew Blauvelt
LSLinyu Shi
Linyu Shi
LTLam C. Tsoi
Lam C. Tsoi
RBRachael Bogle
Rachael Bogle
JGJohann Gudjonsson
Johann Gudjonsson

11 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAndrew Blauvelt
Andrew Blauvelt
RJRundong Jiang
Rundong Jiang
LSLinyu Shi
Linyu Shi
LTLam C. Tsoi
Lam C. Tsoi
RBRachael Bogle
Rachael Bogle
BEBenjamin D. Ehst
Benjamin D. Ehst
The phase 2 KNOCKOUT (NCT05283135) study evaluates higher-than-approved doses of risankizumab, an interleukin-23 inhibitor, for treatment of moderate-to-severe plaque psoriasis. Patients received either 300 or 600 mg of risankizumab at Weeks 0, 4, and 16 and were monitored for 100 weeks without further dosing. Efficacy and safety were tracked throughout the study and lesional/non-lesional tissue was evaluated by RNASeq. The primary endpoint was the change in baseline in number and/or function of tissue resident memory T cells (TRM) at week 52. The secondary endpoints were Psoriasis Areas and Severity Index (PASI) 100 at weeks 28, 40, and 52 and safety events over 100 weeks. Nine patients per treatment group completed dosing. At Weeks 28 and 52, PASI 75/90/100 responses were: 94.4%/94.4%/83.3% and 77.8%/61.1%/44.4% of all patients, respectively, with no new safety signals. At Week 52, TRM cell numbers in lesional skin were markedly reduced, with numbers similar to non-lesional TRM numbers at Week 0. High skin clearance rates with higher-than-approved initial dosing of risankizumab with prolonged maintenance of skin clearance, despite the lack of continuous dosing, represent a potential alternative treatment strategy for patients with psoriasis.

7 November 2025 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
RJRundong Jiang
Rundong Jiang
ZFZhiqin Fang
Zhiqin Fang
LTLam C. Tsoi
Lam C. Tsoi
JGJohann Gudjonsson
Johann Gudjonsson
Disease states are increasingly recognized as being shaped by spatially organized inflammatory niches, in which immune and non‐immune cells coordinate diverse biological processes, including tissue development, homeostasis and pathology. The activation and composition of specific inflammatory responses, as well as the signalling pathways involved, are highly context‐ and location‐dependent. Recent technological advances—particularly the integration of single‐cell sequencing with spatial profiling—have greatly enhanced our ability to dissect these processes at a molecular level. Such approaches have revealed disease‐specific mechanisms, including IL‐36‐driven feed‐forward amplification in the upper layers of psoriatic epidermis, the complex inflammatory architecture of hidradenitis suppurativa and T‐cell–basal keratinocyte interactions in lichen planus. Continued investigation of inflammatory niches across diseases will deepen our understanding of their pathogenic mechanisms, enable the identification of patient‐specific cellular networks and pave the way for more personalized therapeutic strategies.

14 March 2026 in Nature Communications
Verified
Journal Article
Open access
RJRundong Jiang
Rundong Jiang
RBRachael Bogle
Rachael Bogle
XXXianying Xing
Xianying Xing
JKJoseph Kirma
Joseph Kirma
JFJennifer Fox
Jennifer Fox
JGJohann Gudjonsson
Johann Gudjonsson
Lichen planus (LP) is a chronic inflammatory disease of the skin and mucous membranes, marked by T cell infiltration and keratinocyte apoptosis. However, its immune microenvironment remains poorly understood. Using single-cell RNA sequencing, spatial transcriptomics, and proteomics on samples from 28 patients and 18 healthy controls, we identify elevated interferon (IFN) and cytotoxic signatures in CXCL13+CD8+ T cells in both cutaneous and mucosal LP, but not in lichen planopilaris. T cells expressing TNF and IFNG are spatially linked to epithelial cells through ligand-receptor interactions, correlating with inflammation. We identify cDC2A cells as key contributors, proximal to CXCL13+CD8+ T cells, serving as a major source of IL-15. CXCL13+CD8+ T cells express TNFRSF9 (4-1BB), which enhances their cytotoxic responses in the skin. In summary, our data reveal a critical role for cDC2A in driving CXCL13+CD8+ T-epithelial cytotoxicity in cutaneous and mucosal LP through TNFRSF9.